Clinical trials
Phase 2 Thyroid Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Amgen | 1 |
| Apollomics Inc. | 1 |
| Bayer | 1 |
| Eisai Inc. | 1 |
| Genzyme, a Sanofi Company | 1 |
| Ottawa Regional Cancer Centre | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 9 |
| Thyroid Cancer, Papillary | 3 |
| Brain Neoplasms | 2 |
| Breast Neoplasms | 2 |
| Carcinoma, Medullary | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colonic Neoplasms | 2 |
| Glioblastoma | 2 |
| Head and Neck Neoplasms | 2 |
| Kidney Neoplasms | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.